Research & Development: Page 51

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Giving Back

    The PharmaVOICE 100 honorees share a sincere desire to give back. Their philanthropic endeavors range from participation in company-based service days to providing resources and assistance to their communities, schools, and national and global organizations. Favorite charities American Cancer Soc...

    By Taren Grom • July 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Alternate Professions

    What profession, other than theirs, would the PharmaVOICE 100 like to attempt? Not surprising, several of the honorees ­identified teaching as their alternate profession of choice, while others have an affinity for blogging, building, and blending art and science. Dr. Sharon Presnell would work i...

    By Taren Grom • July 29, 2013
  • cancer healthcare Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Oncology

    As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    First Jobs

    First Jobs What was their first job? We thought it would be fun to know how these highly ­successful executives earned their first paychecks. As it turns out, many of them got their start in business by ­mowing lawns, delivering ­papers, or working in food service. Christine Pierre ran a babysitt...

    By Taren Grom • July 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Place of Birth

    Place of Birth Where they were born? Christine Pierre and Steve Collis were born 10,532 miles (16,945.99 kilometers) apart, but they share a global ­perspective on improving healthcare. Dr. Dominic Behan, Tim Davis, Jamie Heywood, Joanne Kamens, Dr. Daniel Kraft, Andrea McGonigle, Mike Rea have t...

    By Taren Grom • July 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Clinical Specialists

    The Clinical Specialists Kent Thoelke Making a Difference Around the World Driven. Thoughtful. During his career in clinical research, Kent Thoelke has ­established an inspiring, industry-wide reputation for moving the current clinical drug development paradigm toward a more ­evidence-based strat...

    By Taren Grom • July 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Commanders & Chiefs

    David Hahn On the Money with Knowledge and Foresight In a hyper-competitive business climate, success requires constant innovation. For David Hahn, this means constantly improving to meet clients’ expectations. Mr. Hahn has been an integral part of the success of The Medical Affairs Company (TMAC...

    By PharmaVoice Team • July 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaVOICE 100 - Who's on the List by Section

    The Commanders & Chiefs David Berry Pronutria Damian Braga Sanofi Pasteur David Bruggeman Clinical Research Advantage Walter Capone The Multiple Myeloma Research Foundation Steve Collis AmerisourceBergen Corp. Nick Colucci Publicis Healthcare Communications Group Jim Curtis Remedy Health Medi...

    By Taren Grom • July 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Talent Pool By Ann Grey Pharma Pool Dave Lemus Sigma-Tau Pharmaceuticals Names CEO Sigma-Tau Pharmaceuticals Inc. has promoted Dave Lemus to the newly created position of CEO. Mr. Lemus had served as chief operating officer of the company since March 2012 and he joined the company as VP of financ...

    By Ann Grey • July 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    August 5, Medicare Chronic Care Pre-Conference Workshop Hyatt Regency Orange County, Garden Grove, Calif. Opal Events, http://www.opalevents.org/p/92/medicare-chronic-care-pre-conference-workshop August 5-7 Active Pharmaceutical Ingredient (API) and Drug Product Specifications The Hilton Los Ange...

    By PharmaVoice Team • July 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Trending Now: Payer approaches to specialty drugs reveal innovation and experimentation as payers navigate this dynamic healthcare marketplace. Ensuring the appropriate use of specialty drugs is a major priority for health plans today and will become increasingly important for their future growth...

    By Denise Myshko • July 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Sunshine Act Compliance MMIS Launches Spend Solution for Smaller Companies E-UPGRADES Veeva Systems Introduces ­Customer Master Solution Tools of the Trade Trending Now: Software-as-a-service solution provides cus...

    By Denise Myshko • July 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    2013 PharmaVOICE 100 - Who's on the List by Company

    2013 PharmaVOICE 100 – Who’s on the List by Company Indexed by Company Affiliation Accelrys Ken Rapp Acorda Therapeutics Denise Duca Acurian Kristin Gross Addgene Dr. Joanne Kamens Advanced Clinical Concepts David Rear Agano Solutions and Auditgraph Mauricha Marcussen AmerisourceBergen Corp. Stev...

    By Taren Grom • July 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Letter from the Editor By Taren Grom The 2013 PharmaVOICE 100 Each year we have the privilege of showcasing 100 of the most inspiring and motivational individuals throughout the life-sciences industry. This special issue, now in its ninth year, once again showcases the individuals as identified b...

    By Taren Grom • July 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Take the Express Toward NDA Approval

    Pharmaceutical manufacturers spend on average $1 billion developing a product for commercialization. With this tremendous investment, it is a pharmaceutical developer’s nightmare to have its product fail during the New Drug Application (NDA) filing process due to safety concerns or lack of pharma...

    By Michael O'Gorman • May 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Defining Innovation Differently

    Innovation, it seems, is the buzzword in every business strategy plan. It’s what pharmaceutical training has always taught us to aspire to. We all want to stay ahead of the curve. And yet, like most of the words in the dictionary, how many ideas are truly new? How many are truly innovative? Well,...

    By Mark A. Lanfear • May 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Successful Strategic Partnering

    Urgent and competing demands are challenging the clinical development efforts of today’s biopharmaceutical companies. Pressures to enhance innovation, feed pipelines, and improve efficiency and quality, all while lowering costs in an evolving regulatory environment are more acute than ever before...

    By Brenda Hoeper • May 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Maximizing Speed to Market by Empowering the Human Element

    Under greater public scrutiny in an increasingly environmentally conscious world, Dow Chemical launched a new advertising campaign in 2008 to demystify the people behind the science of the products it developed. This award-winning campaign, called “the Human Element," featured stunning photos of ...

    By Michael R. Waldman • May 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Can We Make Monitoring Better? That's the $5 Billion Question.

    Incredibly, only 6 percent of new pharmaceutical products ever recoup their development costs. Any other industry would simply cease production of such an unprofitable venture. But we don’t have that luxury. We need to change the way we do things and reduce resource-sapping redundancies. And that...

    By Amy Kissam • May 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    This Old House: Conducting A Clinical Trial Energy Audit

    Our local utility company offers free “energy audits." An auditor will check the robustness of your heating, ventilation, and air conditioning (HVAC) systems and examine your home’s physical envelope — walls, floors, windows, doors — to assess it for leaks. When you live in New England (cold wint...

    By Denise Derenzo Lacey • May 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Clinical Transformation: More Than A Solution It's A New Way To Work

    To succeed in today’s global competitive market, drug companies need to innovate and pursue efficient ways of conducting clinical trials to shorten cycle times and achieve cost savings. As an answer to these new challenges, companies need an integrated and holistic solution based on process optim...

    By Bhaskar Sambbasivan • May 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Artificial Intelligence Improves Pharma Efficiency

    As I consult with clients, I see that technology will ultimately be the driver behind pharmaceutical and biotechnology advancements in the coming decade. I believe that the use of artificial intelligence (AI) is a prime example of innovative efficiencies to come. More than 15 years ago, when I wa...

    By G. Steven Geis • May 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Monitoring Cardiac Safety: Minimizing Risk For Your Next Clinical Trial

    Many drugs used to treat non-cardiac conditions are known to have off-target cardiovascular effects including arrhythmias, hypertension, and reduced ventricular function, which may lead to increased cardiac risk and possibly death. This presents a major challenge not only for clinicians who admin...

    By Mark Weinstein • May 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Electronic Patient Reported Outcomes and Integrated Systems: Effective Solutions for Enhanced Compliance and High Data Quality

    With all the elements that comprise a clinical trial — from design to enrollment to analysis — it is little wonder that success can be impeded by challenges along the way. Use of Electronic Patient Reported Outcome Technologies Low patient compliance and low data quality of Patient Reported Outco...

    By Valarie Higgins • May 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovative Israel Creates Pharma Opportunity

    The state of Israel is one of the most advanced economies in the southwest Asia region, and is rated 38th out of 185 nations worldwide on the World Bank’s Ease of Doing Business Index. Often described as a start-up nation, Israel hosts more NASDAQ-listed companies per citizen than any other count...

    By Kim Ribbink • May 29, 2013
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    2013 DIA Preview

    2013 DIA Preview This year’s theme: Advancing Therapeutic Innovation and Regulatory Science. The Drug Information Association’s 49th Annual Meeting will be held June 23 to 27 at the Boston Convention & Exhibition Center. There will be more than 250 sessions covering 22 tracks on hot topics fr...

    By Taren Grom • May 29, 2013